The FDA approves first U.S. at-home tool as a Pap-smear alternative
The Food and Drug administration has approved the U.S.’s first at-home alternative to the Pap smear, a procedure generations of women have dreaded and often found painful.
The new device by Teal Health will offer a “much preferred experience,” the company said in its announcement, and also aims to increase screening rates by making the procedure more convenient.
Traditionally, gynecologists have inserted a cold metal speculum deep into a woman’s vagina to scrape cells from the cervix.
The Teal Wand — “built with empathy,” the company said — uses a swab to collect a vaginal sample. Women will then mail the sample to a lab that will screen for HPV (human papillomavirus), the virus that causes nearly all cervical cancers. A growing body of research has found HPV testing to be highly accurate.
The FDA approval Friday follows a U.S.-based study that found at-home screening was just as effective as that done in a doctor’s office. The study also found women overwhelmingly preferred self–screening at home, and said they’d be more likely to stay up to date with cervical cancer screenings that way.
Every year, about 13,000 cases of cervical cancer are diagnosed, and more than 4,000 women die from the disease. Rates are down dramatically since Dr. Georgios Papanicolaou published a 1943 paper on how to use the Pap smear for screening, and it then became common.
But about a quarter of women in the U.S. are behind on such screenings, and medical experts say reducing that is key to the ultimate goal of eliminating cervical cancer. There’s also a racial gap, with Black and Native American women far more likely to die from cervical cancer than white women. The HPV vaccine for teen and preteen girls, introduced in 2007, has also led to a global push to tackle the disease that way.
At-home cervical cancer screenings are already available in several other countries, including Australia and Sweden.
Teal Health says its self-testing device will be available starting next month, in California first and then expanding. It will be by prescription, through a telehealth service, for women 25-65 years old who are “at average risk.” The company says it’s working with insurance companies to provide coverage.
DHS ends Temporary Protected Status for thousands from Nicaragua and Honduras
Some 76,000 people from Nicaragua and Honduras were covered by TPS, which provides protection from deportation and grants work permits to people from certain nations affected by war or natural disasters.
BRICS nations push back as Trump warns of tariffs
Leaders of the BRICS group of emerging economies meeting for their annual summit had hoped to downplay any differences with the U.S. But even a toned down group proclamation drew the ire of President Trump.
DOJ says no evidence Jeffrey Epstein had a ‘client list’ or blackmailed associates
The two-page memo outlines the "exhaustive review" the department conducted of the Epstein files in its possession, and also reiterates that Epstein died by suicide, contrary to some conspiracy theories.
Floods are getting more dangerous around the country, not just in Texas
The deadly floods in Central Texas were caused by extremely heavy rain. Climate change is causing even more rain to fall during the heaviest storms.
Near old Montana mine, special clinic for asbestos-related illness fights to survive
The Center for Asbestos Related Disease in Libby, Montana, closed in May after a court judgment. The clinic's federal funding is also threatened. Patients with scarred lungs worry about what's next.
4 things to know about the deadly Texas floods and ongoing search efforts
Search efforts continue for the dozens of people still missing after Friday's floods, as questions swirl over what went wrong. Here's what we know so far.
